Advanced Systemic Mastocytosis Advsm clinical trials

Explore recruiting advanced systemic mastocytosis advsm clinical trials.

Recruiting advanced systemic mastocytosis advsm studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Systemic Mastocytosis Advsm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, open-label, 2-arm study evaluating BLU-263 as monotherapy and in combination with azacitidine, in patients with KIT altered hematologic malignancies

Belgium, Spain, France, Netherlands, Norway, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Systemic Mastocytosis Advsm trials by city

Advanced Systemic Mastocytosis Advsm in Toronto Advanced Systemic Mastocytosis Advsm in Vancouver Advanced Systemic Mastocytosis Advsm in Montreal Advanced Systemic Mastocytosis Advsm in Calgary Advanced Systemic Mastocytosis Advsm in Edmonton Advanced Systemic Mastocytosis Advsm in Ottawa Advanced Systemic Mastocytosis Advsm in Winnipeg Advanced Systemic Mastocytosis Advsm in Quebec City Advanced Systemic Mastocytosis Advsm in Hamilton Advanced Systemic Mastocytosis Advsm in Kitchener Advanced Systemic Mastocytosis Advsm in London Advanced Systemic Mastocytosis Advsm in Halifax Advanced Systemic Mastocytosis Advsm in New York Advanced Systemic Mastocytosis Advsm in Los Angeles Advanced Systemic Mastocytosis Advsm in Chicago Advanced Systemic Mastocytosis Advsm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease